BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38681770)

  • 21. Anthropometric measures as predictors of cardiovascular disease risk factors in the urban population of Iran.
    Gharakhanlou R; Farzad B; Agha-Alinejad H; Steffen LM; Bayati M
    Arq Bras Cardiol; 2012 Feb; 98(2):126-35. PubMed ID: 22231916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonographic fatty liver in overweight and obese children, a cross sectional study in Isfahan.
    Adibi A; Kelishadi R; Beihaghi A; Salehi H; Talaei M
    Endokrynol Pol; 2009; 60(1):14-9. PubMed ID: 19224500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study.
    Hosseini N; Talaei M; Dianatkhah M; Sadeghi M; Oveisgharan S; Sarrafzadegan N
    Metab Syndr Relat Disord; 2017 Sep; 15(7):354-362. PubMed ID: 28677982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study.
    Cameron AJ; Dunstan DW; Owen N; Zimmet PZ; Barr EL; Tonkin AM; Magliano DJ; Murray SG; Welborn TA; Shaw JE
    Med J Aust; 2009 Aug; 191(4):202-8. PubMed ID: 19705980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?
    Khosravi-Boroujeni H; Ahmed F; Sadeghi M; Roohafza H; Talaei M; Dianatkhah M; Pourmogaddas A; Sarrafzadegan N
    BMC Public Health; 2015 Dec; 15():1313. PubMed ID: 26715355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the first nationwide survey on non-communicable disease risk factors and different definitions to evaluate the prevalence of metabolic syndrome in Burkina Faso.
    Cissé K; Samadoulougou DRS; Bognini JD; Kangoye TD; Kirakoya-Samadoulougou F
    PLoS One; 2021; 16(8):e0255575. PubMed ID: 34351987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Dietary Inflammatory Index with cardiovascular disease in Kurdish adults: results of a prospective study on Ravansar non-communicable diseases.
    Ayeneh Pour A; Moradinazar M; Samadi M; Hamzeh B; Najafi F; Karimi S; Faraji F; Darbandi M; Pasdar Y
    BMC Cardiovasc Disord; 2020 Oct; 20(1):434. PubMed ID: 33028205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and associated factors of overweight/obesity and abdominal obesity in South-eastern of Iran: a cross-sectional study based on Rafsanjan cohort study.
    Sadeghi T; Soltani N; Jamali Z; Ayoobi F; Khalili P; Shamsizadeh A; Nasirzadeh M; Esmaeili-Nadimi A; Vecchia C; Jalali Z
    BMC Public Health; 2023 May; 23(1):861. PubMed ID: 37170238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study.
    Shab-Bidar S; Hosseini-Esfahani F; Mirmiran P; Hosseinpour-Niazi S; Azizi F
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():98-108. PubMed ID: 23731333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cohort profile: the Lanxi Cohort study on obesity and obesity-related non-communicable diseases in China.
    Wei C; Ye S; Ru Y; Gan D; Zheng W; Huang C; Chen L; Gao P; Li J; Yang M; Yang F; Zhao X; Zhu S
    BMJ Open; 2019 May; 9(5):e025257. PubMed ID: 31076469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overweight, obesity and related non-communicable diseases in Asian Indian girls and women.
    Chopra SM; Misra A; Gulati S; Gupta R
    Eur J Clin Nutr; 2013 Jul; 67(7):688-96. PubMed ID: 23612512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and predictors of cardiovascular diseases in Kherameh cohort study: a population-based study on 10,663 people in southern Iran.
    Baeradeh N; Ghoddusi Johari M; Moftakhar L; Rezaeianzadeh R; Hosseini SV; Rezaianzadeh A
    BMC Cardiovasc Disord; 2022 May; 22(1):244. PubMed ID: 35643460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden and predisposing factors of non-communicable diseases in Mashhad University of Medical Sciences personnel: a prospective 15-year organizational cohort study protocol and baseline assessment.
    Tohidinezhad F; Khorsand A; Zakavi SR; Rezvani R; Zarei-Ghanavati S; Abrishami M; Moradi A; Tavakoli M; Farrokh D; Rad MP; Abbasi B; Ahadi M; Saleh LA; Tayebi M; Amini M; Poustchi H; Abu-Hanna A; Eslami S
    BMC Public Health; 2020 Nov; 20(1):1637. PubMed ID: 33138802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clustering of cardio metabolic risk factors in Iranian adult population: A growing problem in the north of Iran.
    Hajian-Tilaki K; Heidari B; Firouzjahi AR
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S277-S281. PubMed ID: 28420579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-communicable diseases and related risk behaviors among men and women living with HIV in Cambodia: findings from a cross-sectional study.
    Chhoun P; Ngin C; Tuot S; Pal K; Steel M; Dionisio J; Pearson H; Mburu G; Brody C; Yi S
    Int J Equity Health; 2017 Jul; 16(1):125. PubMed ID: 28705242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cohort profile: Bandar Kong prospective study of chronic non-communicable diseases.
    Nejatizadeh A; Eftekhar E; Shekari M; Farshidi H; Davoodi SH; Shahmoradi M; Poustchi H; Ghanbarnejad A; Aghamolaei T; Yousefi H; Rafati S
    PLoS One; 2022; 17(5):e0265388. PubMed ID: 35550629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States.
    Daviglus ML; Talavera GA; Avilés-Santa ML; Allison M; Cai J; Criqui MH; Gellman M; Giachello AL; Gouskova N; Kaplan RC; LaVange L; Penedo F; Perreira K; Pirzada A; Schneiderman N; Wassertheil-Smoller S; Sorlie PD; Stamler J
    JAMA; 2012 Nov; 308(17):1775-84. PubMed ID: 23117778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030.
    Farzadfar F; Yousefi M; Jafari-Khounigh A; Khorrami Z; Haghdoost A; Shadmani FK
    Sci Rep; 2024 Apr; 14(1):8092. PubMed ID: 38582931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.
    Kouvari M; Chrysohoou C; Skoumas J; Pitsavos C; Panagiotakos DB; Mantzoros CS;
    Metabolism; 2022 Mar; 128():154893. PubMed ID: 34600906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.